A股異動 | 精功科技漲5.55% 籌劃收購精功機器人40%股權
格隆匯1月10日丨精功科技漲5.55%,報26.99元,總市值123億元。精功科技昨晚公吿稱,公司持有精功機器人60%股權,其餘40%股權由智傑科技持有。公司近期擬籌劃收購精功機器人少數股東權益,即收購智傑科技所持有的精功機器人40%股權。公司擬通過整體吸收合併方式合併精功機器人,吸收合併完成後,精功機器人將不再存續。目前,上述事項尚處於籌劃階段,交易方案以及具體交易方式、交易對價等均不確定。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.